Accès ouvert
2026
article
OpenAlex
Ryo Iketani, Shinobu Imai
Importance: Japan's family pharmacist system (FPS) has helped to prevent therapeutic duplication and drug interactions and to improve leftover drug adjustments. However, its association with lower risk of death or hospitalization remains unclear. Objective: To examine the risk of death or hospitalization …
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ryo Iketani
BACKGROUND: The kakaritsuke-yakuzaishi system (hereafter called the family pharmacist system), which provides more pharmaceutical services in exchange for higher fees than do general pharmacy practices, was introduced in Japan in April 2016. This cohort study aimed to describe the characteristics of patients …
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Ryo Iketani
Accès ouvert
2023
article
OpenAlex
Ryo Iketani, Shinobu Imai
In April 2014, sodium-glucose cotransporter 2 inhibitor (SGLT-2i) was introduced in Japan. In May 2015, the prescription limitation for SGLT-2i was lifted. Subsequently, SGLT-2i was shown to reduce cardiovascular events in patients with type 2 diabetes mellitus (T2DM). SGLT-2i prescription is expected …
la, jp
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Ryo Iketani, Shinobu Imai
WHAT IS KNOWN AND OBJECTIVE: Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) have been increasingly prescribed for the treatment of type 2 diabetes mellitus (T2DM). We aimed to investigate the impact of clinical trials presenting remarkable results on the prescription of SGLT-2is and the relationship …
jp
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Ryo Iketani, Keiko Konomura
BACKGROUND: The kakaritsuke-yakuzaishi system (henceforth, the family pharmacist system) which provides more health services than those by general pharmaceutical practice, was implemented in Japan in April 2016. To distribute medical resources and medical care expenditures appropriately, identifying the possible major beneficiaries of …
jp
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Ryo Iketani, Keiko Konomura
This retrospective cohort study aimed to evaluate the utility of the family pharmacist system using administrative claims data. The eligible cohort was detected from the JMDC claims database; it was divided into two groups-those using the system (users) and those not using …
la
(code pays fourni par la source)
2021
article
OpenAlex
Ryo Iketani, Keiko Konomura
2021
article
OpenAlex
Ryo Iketani
Accès ouvert
2021
article
OpenAlex
Ryo Iketani, Keiko Konomura
The present nested case-control study aimed to clarify the type of patients with type 2 diabetes mellitus that required concentrated pharmaceutical management in health insurance pharmacies by detecting factors associated with the calculation of chouhukutouyaku-sougosayoutou-boushi-kasan. We detected the factors of patients on …
la
(code pays fourni par la source)
2021
article
OpenAlex
Ryo Iketani, Keiko Konomura
Accès ouvert
2020
review
OpenAlex
Ryo Iketani, Daisuke Furushima, Shinobu Imai, Hiroshi Yamada
jp
(code pays fourni par la source)